Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer
In non-small cell lung cancer (NSCLC), the heterogeneity promotes drug resistance, and the restricted expression of programmed death-ligand 1 (PD-L1) limits the immunotherapy benefits. Based on the mechanisms related to translation regulation and the association with PD-L1 of methyltransferase-like...
Saved in:
Main Authors: | Han Xiao (Author), Rong Zhao (Author), Wangyang Meng (Author), Yongde Liao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
by: Yue Du, et al.
Published: (2022) -
Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
by: Jiayi Shen, et al.
Published: (2024) -
Small Molecule Inhibitors of Influenza Virus Entry
by: Zhaoyu Chen, et al.
Published: (2021) -
METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer
by: Dongcheng Liu, et al.
Published: (2020) -
Small Molecule Inhibitors of CRM1
by: Bibiana I. Ferreira, et al.
Published: (2020)